Torrent Pharmaceuticals Ltd. Gains on FDA Nod for Generics of Actos

Published: Feb 15, 2013

Torrent Pharmaceuticals gained more than one percent intraday on Friday as the company received approval from US FDA for generics of Actos and Actoplus Met. Takeda Global's Actos and Actoplus are anti-diabetes drugs. At 15:08 hours IST, shares rose 0.71 percent to Rs 700 on Bombay Stock Exchange.

Back to news